Member Info for Early_Bird

Nambia CPR was carried out independently by Netherland Sewell and Associates Inc. (�NSAI"). The only internal estimate is for the Kenitra Prospect in Moroco... Namibia incidently is attributed a 29% COS which is about as high as you can possibly get for a wildcat. Exciting times for those getting in down here.... �22-24m in cash as a safety net.

https://www.youtube.com/watch?v=88gjfdleVcM Given $75 oil price and low rig rates, the fact CHAR can fully funded Namibia without a farm in partner means they in a prime postion to get extemely favourable terms for the farm in partner.

Worth watching to recap.. https://www.youtube.com/watch?v=88gjfdleVcM

With 350mmbol net for the Namibia drill this will be 16-25p comfortably by spud of this well IMHO given upside. Farm in before then of course is a nearer term upside catalyst. 350mmbol net is the largest net attributable drill on AIM this year I believe and its all there fully funded. Risk v reward is absolutely key, buying here at cash +10% is absolute as low risk strategy as you can get. For clarity I never hold for drill result on wildcat... thats a mugs game and its pure gamlbing. Ill sell all of my holding here prior to spud thus taking the risk out the equation. Thats how I gear the odds in my favour.... ill leave speculators such as yourself to buy my shares off me 16p+ a month or so before spud.. Cheers

With 350mmbol net for the Namibia drill this will be 16-25p comfortably by spud of this well IMHO given upside. Farm in before then of course is a nearer term upside catalyst. 350mmbol net is the largest net attributable drill on AIM this year I believe and its all there fully funded. Risk v reward is absolutely key, buying here at cash +10% is absolute as low risk strategy as you can get. For clarity I never hold for drill result on wildcat... thats a mugs game and its pure gamlbing. Ill sell all of my holding here prior to spud thus taking the risk out the equation. Thats how I gear the odds in my favour.... ill leave speculators such as yourself to buy my shares off me 16p+ a month or so before spud.. Cheers

Do the exact opposite to this chap ^ and you wont be far off from a great trading strategy. Key is to buy low and sell high. Logic key.

CHAR is a wildcat explorer. COS clearly stated was 3 times more likely to be a duster. I suggest you have a look at your own investment strategy if you are treating CHAR as anything other than a wildcat explorer you are yourself the one with the issue and not the company. Id also argue now the �15m raise at 13p is looking like a rather wise move! Another roll of the dice H2 with a much larger drill.. fully funded with Farm in on this licence incoming.

�24m in the bank, no debt.. huge 300mmbol net spudding H2 fully funded. Farm-in for this to come could mean more cash than current MC. MC �29m no brainer BUY for me

you do realize the COS was only 25%... it was always way more likely to be a duster... thats wildcat exploration. The trade was *always* buying in now on duster for the much bigger(net) H2 drill (fully funded). Amazing how each drill is a totally mutually elusive event with one having absolutely no bearing on the other.... people link one bad drill result in morocco to Namibia with completely different geology/trap/sourcerock is totally irrational. I cant see this going below 7.5p

�24m in the bank currently and fully funded (without farm in) for Namibia. Farm-in im expecting imminently as next big catalyst

currently sitting at �30m mcap �22-24m in cash and fully funded for 300mmbol NET drill in H2. Cant ignore the value

Heat slowly turning up here, very excited for Zamsort news... long time coming and has the potential to blow the doors off here.

strong.

Great day yesterday but really just the very start. broker target of 113p and this is imo easily achievable due to the multibillion dollar markets and the sheer scalability of the Sulforadex technology in so many different disease areas. Imo once phase 2 is proven up Evgen will be subject to a bid from big pharma, make no mistake this is a biggy with blue sky potential, IMM went from 30p to 200p last year with a �200m plus mcap without much promotion! Pharma stocks can be explosive and I believe this will be extremely explosive even more so with the tiny free float available. Worth noting Big pharma companies are very interested in SFX-01 and one even tried to buy Evgen shortly before it was floated at 37p back in December 2015 but Franklin and his team want to deliver Phase II data on both breast cancer and SAH before concluding a licensing deal or deals.. well guess what we have the conculsion of these trials commencing this quarter at is down at 22p! 6bn market revenue opportunity for the two current phase 2 trials with the SAS trial already been granted orphan drug designation. SFX-01 also has the opportunity to be used in Austism, MS, arthritis and lots of different cancers, so from the current �15m mcap I cannot see a better Pharma on aim for blue sky multibag potential for 2018. IPO 37p back in 2015 had big ii backing when Phase 2 trials were 2-3 years off! Now we are reaching the sharp end of delivery price is at all time lows. And its fully funded. Such an opportunity.

massive volume here... just the start of what I see as a big rerate as the market cottons on to the upside on offer with catalysts due imminently. Broker Target of 113p (recent & upgraded), IPO 37p with all good news since.. funded and 18p to buy currently...

MMs not allowing a fair market... needs investigation

Near impossible to buy volume, MMs here were allowing 100k to be sold then at the same time not allowing me to buy even 10k shares... Now full ask to buy. Looking primed to me.

http://www.proactiveinvestors.co.uk/columns/northland-capital-partners-view-on-the-city/29626/northland-capital-partners-view-on-the-city-evgen-pharma-lonevg-alexander-mining-lonasm-n4-pharma-lonn4p-29626.html Current SP... 14p. When this share starts to get on radars, with the Q2 and H2 readouts getting ever closer and PR starts to ramp up I see an almighty rerate here. Time is nigh.

Building nicely here since my buy call at 8-9p. wont be long now until the next set of drill results... next month. Anyone remember the last set? http://www.prweb.com/releases/2017/05/prweb14301575.htm still 60% gain to take us back to placing level which had big ii backing. Fundamentals now arguably much stronger than back then too.

Anglo African�s initial work programme for Tilapia has been to workover two existing wells (TLP-101 and TLP-102) and drill two new wells (TLP-103 and TLP-104). It has now completed the workover of drill TLP-101. The well was first brought into production over 10 years ago and had a production of 38bopd at Anglo African�s IPO. Earlier this month, Anglo African announced that it had cleared a build-up of wax that had accumulated over a very long time. Berwick described the build-up as �absolutely horrendous�: �At some points, the flow lines were producing through just 1cm in diameter. We have completely dismantled the entire flowline section. We cleaned through the separator, the flowlines, and the wellhead. The flowlines have now been welded back together ready to be brought back into production today.�